Stock Events

Stock Events

ZYUS Life Sciences 

$0.040000
2
-$0.00-0% Thursday 13:30

Statistics

Day High
0.04
Day Low
0.04
52W High
0.59
52W Low
0.04
Volume
-
Avg. Volume
-
Mkt Cap
3.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
-0.06
-0.05
-0.04
-0.03
Expected EPS
N/A
Actual EPS
N/A

Financials

-6,947.62%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
683,474Revenue
-47.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZLSCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1B
Cronos Group is involved in the production and sale of cannabis in multiple countries, competing with ZYUS in the global cannabis market.
Tilray Brands
TLRY
Mkt Cap601.68M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor in these areas.
Canopy Growth
CGC
Mkt Cap449.08M
Canopy Growth Corporation operates in the medical cannabis sector, directly competing with ZYUS in developing and marketing cannabis-based products.
Aurora Cannabis
ACB
Mkt Cap188.3M
Aurora Cannabis is engaged in the production and distribution of medical cannabis, competing in the same regulatory and consumer markets as ZYUS.
Curaleaf
CURLF
Mkt Cap2.76B
Curaleaf Holdings, Inc. is a provider of consumer products in cannabis, competing in the U.S. market where ZYUS also operates.
Organigram Global
OGI
Mkt Cap149.22M
Organigram Holdings focuses on the production of cannabis for medical and recreational purposes, competing with ZYUS in the medical segment.

About

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
Show more...
CEO
Mr. Brent H. Zettl
Country
Canada
ISIN
CA9899601095

Listings

OTC Link
US
ZLSCF
V
CA
ZYUS.V

0 Comments

Share your thoughts

FAQ

What is ZYUS Life Sciences stock price today?▼
The current price of ZLSCF is $0.04 USD — it has decreased by -0% in the past 24 hours. Watch ZYUS Life Sciences stock price performance more closely on the chart.
What is ZYUS Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ZYUS Life Sciences stocks are traded under the ticker ZLSCF.
Is ZYUS Life Sciences stock price growing?▼
ZLSCF stock has fallen by -0% compared to the previous week, the month change is a -89.14% fall, over the last year ZYUS Life Sciences has showed a -93.22% decrease.
What is ZYUS Life Sciences market cap?▼
Today ZYUS Life Sciences has the market capitalization of 3.13M
What is ZYUS Life Sciences revenue for the last year?▼
ZYUS Life Sciences revenue for the last year amounts to 683,474 USD.
What is ZYUS Life Sciences net income for the last year?▼
ZLSCF net income for the last year is -47.49M USD.
In which sector is ZYUS Life Sciences located?▼
ZYUS Life Sciences operates in the Health & Wellness sector.
When did ZYUS Life Sciences complete a stock split?▼
The last stock split for ZYUS Life Sciences was on June 19, 2023 with a ratio of 1.090141:1.
Where is ZYUS Life Sciences headquartered?▼
ZYUS Life Sciences is headquartered in Saskatoon, Canada.